Neurologic Damage and Neurocognitive Dysfunction in Urea Cycle Disorders

Seminars in Pediatric Neurology

Volumn 15, Issue 3, 2008, Pages 132-139

  Enns, Gregory M ^a  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AMMONUL; ANTIOXIDANT; ARGINASE; ARGININE; BENZODIAZEPINE RECEPTOR; BENZOIC ACID; CALCIUM ION; CYCLIC GMP; FREE RADICAL; GLUTAMATE SYNTHASE; GLUTAMIC ACID; GLUTAMINE; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLACETIC ACID DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; SODIUM PHENYLACETATE PLUS SODIUM BENZOATE; UREA;

BRAIN DISEASE; BRAIN EDEMA; CHILD; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; DIALYSIS; ELECTROENCEPHALOGRAPHY; ENZYME DEFICIENCY; HEMOFILTRATION; HUMAN; HYPERAMMONEMIA; HYPOTHERMIA; INBORN ERROR OF METABOLISM; INFANT; MENTAL DEFICIENCY; MENTAL DISEASE; MITOCHONDRIAL RESPIRATION; NEUROIMAGING; NEUROTRANSMISSION; NEWBORN; NEWBORN SCREENING; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PATHOGENESIS; PRENATAL DIAGNOSIS; PROTEIN RESTRICTION; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SEIZURE; SURVIVAL RATE; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME; UREA CYCLE;

BRAIN EDEMA; CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE; COGNITION DISORDERS; GLUTAMINE; HUMANS; METABOLISM, INBORN ERRORS; MITOCHONDRIA; SEIZURES; UREA;

EID: 49149086386     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2008.05.007     Document Type: Review

References (73)

1. Gropman A.L., Summar M., and Leonard J.V. Neurological implications of urea cycle disorders. J Inherit Metab Dis 30 (2007) 865-879
2. Harding B.N., Leonard J.V., and Erdohazi M. Ornithine carbamoyl transferase deficiency: A neuropathological study. Eur J Pediatr 141 (1984) 215-220
3. Kornfeld M., Woodfin B.M., Papile L., et al. Neuropathology of ornithine carbamyl transferase deficiency. Acta Neuropathol 65 (1985) 261-264
4. Dolman C.L., Clasen R.A., and Dorovini-Zis K. Severe cerebral damage in ornithine transcarbamylase deficiency. Clin Neuropathol 7 (1988) 10-15
5. Shih V.E. Hereditary urea-cycle disorders. In: Grisolia S., Báguena R., and Mayor F. (Eds). The Urea Cycle (1976), John Wiley, New York, NY 367-414
6. Brusilow S.W., Valle D.L., and Batshaw M. New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 2 (1979) 452-454
7. Batshaw M.L., Brusilow S., Waber L., et al. Treatment of inborn errors of urea synthesis: Activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 306 (1982) 1387-1392
8. Enns G.M., Berry S.A., Berry G.T., et al. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356 (2007) 2282-2292
9. Nassogne M.C., Heron B., Touati G., et al. Urea cycle defects: management and outcome. J Inherit Metab Dis 28 (2005) 407-414
10. Uchino T., Endo F., and Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 21 suppl 1 (1998) 151-159
11. Bachmann C.L. Outcome and survival of 88 patients with urea cycle disorders: A retrospective evaluation. Eur J Pediatr 162 (2003) 410-416
12. Msall M., Batshaw M.L., Suss R., et al. Neurologic outcome in children with inborn errors of urea synthesis Outcome of urea-cycle enzymopathies. N Engl J Med 310 (1984) 1500-1505
13. Nicolaides P., Liebsch D., Dale N., et al. Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch Dis Child 86 (2002) 54-56
14. Maestri N.E., Clissold D., and Brusilow S.W. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr 134 (1999) 268-272
15. Maestri N.E., Hauser E.R., Bartholomew D., et al. Prospective treatment of urea cycle disorders. J Pediatr 119 (1991) 923-928
16. Msall M., Monahan P.S., Chapanis N., et al. Cognitive development in children with inborn errors of urea synthesis. Acta Paediatr Jpn 30 (1988) 435-441
17. Enns G.M., O'Brien W.E., Kobayashi K., et al. Postpartum "psychosis" in mild argininosuccinate synthetase deficiency. Obstet Gynecol 105 (2005) 1244-1246
18. Ahrens M.J., Berry S.A., Whitley C.B., et al. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation. Am J Med Genet 66 (1996) 311-315
19. Gropman A.L., and Batshaw M.L. Cognitive outcome in urea cycle disorders. Mol Genet Metab 81 suppl 1 (2004) S58-S62
20. Gyato K., Wray J., Huang Z.J., et al. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol 55 (2004) 80-86
21. Engel R.C., and Buist N.R. The EEGs of infants with citrullinemia. Dev Med Child Neurol 27 (1985) 199-206
22. Brunquell P., Tezcan K., and DiMario Jr. F.J. Electroencephalographic findings in ornithine transcarbamylase deficiency. J Child Neurol 14 (1999) 533-536
23. Bogdanovic M.D., Kidd D., Briddon A., et al. Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry 69 (2000) 813-815
24. Takanashi J., Barkovich A.J., Cheng S.F., et al. Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol 24 (2003) 1184-1187
25. Mamourian A.C., and du Plessis A. Urea cycle defect: A case with MR and CT findings resembling infarct. Pediatr Radiol 21 (1991) 594-595
26. Bindu P.S., Sinha S., Taly A.B., et al. Extensive cortical magnetic resonance signal change in proximal urea cycle disorder. J Child Neurol 22 (2007) 238-239
27. Gaspari R., Arcangeli A., Mensi S., et al. Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma. Ann Emerg Med 41 (2003) 104-109
28. Majoie C.B., Mourmans J.M., Akkerman E.M., et al. Neonatal citrullinemia: comparison of conventional MR, diffusion-weighted, and diffusion tensor findings. AJNR Am J Neuroradiol 25 (2004) 32-35
29. Fitzpatrick S.M., Hetherington H.P., Behar K.L., et al. Effects of acute hyperammonemia on cerebral amino acid metabolism and pHi in vivo, measured by 1H and 31P nuclear magnetic resonance. J Neurochem 52 (1989) 741-749
30. Kanamori K., and Ross B.D. 15N n.m.r. measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonaemic rat. Biochem J 293 (1993) 461-468
31. Kanamori K., and Ross B.D. In vivo activity of glutaminase in the brain of hyperammonaemic rats measured by 15N nuclear magnetic resonance. Biochem J 305 (1995) 329-336
32. Sibson N.R., Dhankhar A., Mason G.F., et al. In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc Natl Acad Sci U S A 94 (1997) 2699-26704
33. Connelly A., Cross J.H., Gadian D.G., et al. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 33 (1993) 77-81
34. Takanashi J., Kurihara A., Tomita M., et al. Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency. Neurology 59 (2002) 210-214
35. Brusilow S.W. Hyperammonemic encephalopathy. Medicine (Baltimore) 81 (2002) 240-249
36. Kanamori K., Ross B.D., Chung J.C., et al. Severity of hyperammonemic encephalopathy correlates with brain ammonia level and saturation of glutamine synthetase in vivo. J Neurochem 67 (1996) 1584-1594
37. Sibson N.R., Mason G.F., Shen J., et al. In vivo (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during. J Neurochem 76 (2001) 975-989
38. Kanamori K., and Ross B.D. Kinetics of glial glutamine efflux and the mechanism of neuronal uptake studied in vivo in mildly hyperammonemic rat brain. J Neurochem 99 (2006) 1103-1113
39. Takahashi H., Koehler R.C., Brusilow S.W., et al. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 261 (1991) H825-H829
40. Tanigami H., Rebel A., Martin L.J., et al. Effect of glutamine synthetase inhibition on astrocyte swelling and altered astroglial protein expression during hyperammonemia in rats. Neuroscience 131 (2005) 437-449
41. Zwingmann C., and Butterworth R. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: Further studies using NMR spectroscopy. Neurochem Int 47 (2005) 19-30
42. Albrecht J., and Norenberg M.D. Glutamine: A Trojan horse in ammonia neurotoxicity. Hepatology 44 (2006) 788-794
43. Felipo V., and Butterworth R.F. Mitochondrial dysfunction in acute hyperammonemia. Neurochem Int 40 (2002) 487-491
44. Kosenko E., Venediktova N., Kaminsky Y., et al. Sources of oxygen radicals in brain in acute ammonia intoxication in vivo. Brain Res 981 (2003) 193-200
45. Norenberg M.D., Rama Rao K.V., and Jayakumar A.R. Ammonia neurotoxicity and the mitochondrial permeability transition. J Bioenerg Biomembr 36 (2004) 303-307
46. Norenberg M.D., Jayakumar A.R., Rama Rao K.V., et al. New concepts in the mechanism of ammonia-induced astrocyte swelling. Metab Brain Dis 22 (2007) 219-234
47. Bender A.S., and Norenberg M.D. Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J Neurosci Res 54 (1998) 673-680
48. Rama Rao K.V., Chen M., Simard J.M., et al. Suppression of ammonia-induced astrocyte swelling by cyclosporin A. J Neurosci Res 74 (2003) 891-897
49. Jayakumar A.R., Rao K.V., Murthy ChR., et al. Glutamine in the mechanism of ammonia-induced astrocyte swelling. Neurochem Int 48 (2006) 623-628
50. Pichili V.B., Rao K.V., Jayakumar A.R., et al. Inhibition of glutamine transport into mitochondria protects astrocytes from ammonia toxicity. Glia 55 (2007) 801-809
51. Rama Rao K.V., Chen M., Simard J.M., et al. Increased aquaporin-4 expression in ammonia-treated cultured astrocytes. Neuroreport 14 (2003) 2379-2382
52. Szerb J.C., and Butterworth R.F. Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol 39 (1992) 135-153
53. Ratnakumari L., Qureshi I.A., and Butterworth R.F. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency. Metab Brain Dis 9 (1994) 43-51
54. Robinson M.B., Hopkins K., Batshaw M.L., et al. Evidence of excitotoxicity in the brain of the ornithine carbamoyltransferase deficient sparse fur mouse. Brain Res Dev Brain Res 90 (1995) 35-44
55. Bergeron M., Swain M.S., Reader T.A., et al. Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J Neurochem 55 (1990) 222-229
56. Butterworth R.F. Glutamate transporter and receptor function in disorders of ammonia metabolism. Ment Retard Dev Disabil Res Rev 7 (2001) 276-279
57. Christodoulou J., Qureshi I.A., McInnes R.R., et al. Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr 122 (1993) 423-425
58. Itzhak Y., Roig-Cantisano A., Dombro R.S., et al. Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain. Brain Res 705 (1995) 345-348
59. Kosenko E., Llansola M., Montoliu C., et al. Glutamine synthetase activity and glutamine content in brain: Modulation by NMDA receptors and nitric oxide. Neurochem Int 43 (2003) 493-499
60. Kosenko E., Kaminski Y., Lopata O., et al. Blocking NMDA receptors prevents the oxidative stress induced by acute ammonia intoxication. Free Radic Biol Med 26 (1999) 1369-1374
61. Bachmann C., Braissant O., Villard A.M., et al. Ammonia toxicity to the brain and creatine. Mol Genet Metab 81 suppl 1 (2004) S52-S57
62. Izumi Y., Izumi M., Matsukawa M., et al. Ammonia-mediated LTP inhibition: Effects of NMDA receptor antagonists and L-carnitine. Neurobiol Dis 20 (2005) 615-624
63. Monfort P., Munoz M.D., and Felipo V. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia. Metab Brain Dis 20 (2005) 265-274
64. Picker J.D., Puga A.C., Levy H.L., et al. Arginase deficiency with lethal neonatal expression: Evidence for the glutamine hypothesis of cerebral edema. J Pediatr 142 (2003) 349-352
65. Scaglia F., and Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 142 (2006) 113-120
66. Gungor S., Akinci A., Firat A.K., et al. Neuroimaging findings in hyperargininemia. J Neuroimaging (2008) Jan 7; [Epub ahead of print]
67. Wyse A.T., Bavaresco C.S., Hagen M.E., et al. In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia. Brain Res 923 (2001) 50-57
68. Deignan J.L., Marescau B., Livesay J.C., et al. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. Mol Genet Metab 93 (2008) 172-178
69. Scaglia F., Brunetti-Pierri N., Kleppe S., et al. Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. J Nutr 134 suppl (2004) 2775S-2782S
70. Niemi A.K., and Enns G.M. Sodium phenylacetate and sodium benzoate in the treatment of neonatal hyperammonemia. NeoReviews 7 (2006) e486-e3495
71. Lipton S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov 5 (2006) 160-170
72. Natale J.E., Guerguerian A.M., Joseph J.G., et al. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury. Pediatr Crit Care Med 8 (2007) 1-9
73. Whitelaw A., Bridges S., Leaf A., et al. Emergency treatment of neonatal hyperammonaemic coma with mild systemic hypothermia. Lancet 358 (2001) 36-38